First Turn Management »

Bridgebio Pharma shares owned by First Turn Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by First Turn Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $10M 400k 25.46

More positions owned by First Turn Management

Nuvalent Inc-a (NUVL)
Argenx Se Sponsored Adr (ARGX)
Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
Vaxcyte (PCVX)
Axsome Therapeutics (AXSM)
Syndax Pharmaceuticals (SNDX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Natera (NTRA)
Intra Cellular Therapies (ITCI)
Crinetics Pharmaceuticals In (CRNX)
Transmedics Group (TMDX)
Arcellx Common Stock (ACLX)
Blueprint Medicines (BPMC)
Verona Pharma Sponsored Ads (VRNA)

View all positions for First Turn Management

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
BlackRock
BlackRock
Aisling Capital Management
State Street Corporation
Susquehanna International
Henderson Group
Laurion Capital Management
Frazier Life Sciences Management
Geode Capital Management
Citadel Advisors
Pictet Asset Management Holding SA
Jane Street

View all funds holding Bridgebio Pharma